Cargando…
The most important problems and needs of rasopathy patients with a noonan syndrome spectrum disorder
BACKGROUND: Noonan syndrome spectrum disorders (NSSDs) constitute a group within the Rasopathies, and are one of the largest groups of syndromes with impact on multi-organ involvement known. The extreme variability of the clinical phenotype is, among others, due to the numerous different genes that...
Autores principales: | Tiemens, Dagmar K., Kleimeier, Lotte, Leenders, Erika, Wingbermühle, Ellen, Roelofs, Renee L., Sibbles, Barbara, Oostwegel, Floor S.M., Vroonland, Eva, van Leeuwen, Conny, Niessen, Hanneke, Sonnega, Paul, Duursma, Anniek, Willemsen, Michel A. A. P., Draaisma, Jos M. T., Pittens, Carina A.C.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362585/ https://www.ncbi.nlm.nih.gov/pubmed/37480127 http://dx.doi.org/10.1186/s13023-023-02818-y |
Ejemplares similares
-
Patient engagement in the design of clinical research in Noonan syndrome spectrum disorders: a scoping review
por: Tiemens, Dagmar K., et al.
Publicado: (2021) -
Lymphatic Phenotype of Noonan Syndrome: Innovative Diagnosis and Possible Implications for Therapy
por: Kleimeier, Lotte E. R., et al.
Publicado: (2022) -
Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study
por: Swarts, Jessie W., et al.
Publicado: (2022) -
Cognitive Phenotype and Psychopathology in Noonan Syndrome Spectrum Disorders through Various Ras/MAPK Pathway Associated Gene Variants
por: Wingbermühle, Ellen, et al.
Publicado: (2022) -
Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment
por: Carcavilla, Atilano, et al.
Publicado: (2023)